Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes.

Abstract excerpt

It has been found that CDKL5 gene mutations are responsible for early-onset epilepsy and drug resistance. We screened a population of 92 patients with classic/atypical Rett syndrome, 17 Angelman/Angelman-like patients and six idiopathic autistic patients for CDKL5 mutations and exon deletions and identified seven novel mutations: six in the Rett subset and one in an Angelman patient. This last, an insertion in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age of Onset
• Share to Angelman Syndrome
• Share to Autistic Disorder